Portfolio (Quarterly)
Guide ↗
ADAR1 Capital Management, LLC
· CIK 0001940272| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | — | INHIBIKASE THERAPEUTICS INC | — | 6,606,572.0 | $11.1M | 0.65% | NEW | — | $1.68 | — |
| 42 | SPRY | ARS PHARMACEUTICALS INC | Healthcare | 1,361,536.0 | $10.9M | 0.64% | NEW | — | $8.03 | -8.3% |
| 43 | TERN CALL | TERNS PHARMACEUTICALS INC | Healthcare | 200,000.0 | $10.5M | 0.62% | NEW | — | $52.72 | +0.4% |
| 44 | HLXC | HELIX ACQUISITION CORP III | Financial Services | 1,000,000.0 | $10.3M | 0.61% | NEW | — | $10.30 | -0.8% |
| 45 | OVID | OVID THERAPEUTICS INC | Healthcare | 4,544,113.0 | $10.1M | 0.59% | NEW | — | $2.22 | +11.8% |
| 46 | — | ONKURE THERAPEUTICS INC | — | 2,434,941.0 | $10.1M | 0.59% | NEW | — | $4.14 | — |
| 47 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 12,154.0 | $9.4M | 0.55% | NEW | — | $772.64 | -17.9% |
| 48 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 457,137.0 | $8.5M | 0.50% | NEW | — | $18.64 | -11.1% |
| 49 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 1,467,350.0 | $8.4M | 0.50% | NEW | — | $5.74 | -20.9% |
| 50 | — | OPUS GENETICS INC | — | 1,849,004.0 | $8.4M | 0.49% | NEW | — | $4.55 | — |
| 51 | TEVA | TEVA PHARMACEUTICAL INDS LTD | Healthcare | 268,391.0 | $8.1M | 0.48% | NEW | — | $30.12 | +13.1% |
| 52 | SVRA | SAVARA INC | Healthcare | 1,464,535.0 | $8.0M | 0.47% | NEW | — | $5.46 | -13.0% |
| 53 | MPLT | MAPLIGHT THERAPEUTICS INC | Healthcare | 374,909.0 | $7.6M | 0.45% | NEW | — | $20.33 | +32.5% |
| 54 | LONA | LEONABIO INC | Healthcare | 727,481.0 | $7.5M | 0.44% | NEW | — | $10.28 | -2.6% |
| 55 | EQ | EQUILLIUM INC | Healthcare | 3,726,659.0 | $7.5M | 0.44% | NEW | — | $2.00 | -4.8% |
| 56 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 227,717.0 | $7.4M | 0.44% | NEW | — | $32.54 | -12.5% |
| 57 | — | DAMORA THERAPEUTICS INC | — | 279,000.0 | $7.2M | 0.42% | NEW | — | $25.90 | — |
| 58 | URGN | UROGEN PHARMA LTD | Healthcare | 395,459.0 | $7.1M | 0.42% | NEW | — | $17.98 | +58.8% |
| 59 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 94,292.0 | $7.0M | 0.41% | NEW | — | $74.26 | -11.5% |
| 60 | PRME | PRIME MEDICINE INC | Healthcare | 1,973,282.0 | $6.9M | 0.40% | NEW | — | $3.48 | -20.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
94.6%
Financial Services
4.9%
Real Estate
0.1%
Consumer Cyclical
0.1%
Technology
0.1%
Communication Services
0.1%
Industrials
0.1%
Basic Materials
0.1%